back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-07-23 19:53 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-25,287.50
-1,190 vol $21.25 each |
2,020 | |
| Filed 2019-07-23 19:53 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$63,452
+2,986 vol $21.25 each |
3,210 | |
| Filed 2019-07-23 19:52 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,986 vol |
17,921 | |
| Filed 2019-06-26 17:24 Tx date 2019-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-45,567.66
-1,913 vol $23.82 each |
5,843 | |
| Filed 2019-06-26 17:23 Tx date 2019-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$100,877
+4,235 vol $23.82 each |
7,756 | |
| Filed 2019-06-26 17:22 Tx date 2019-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,235 vol |
26,876 | |
| Filed 2019-05-10 18:02 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-17,538.46
-746 vol $23.51 each |
3,521 | |
| Filed 2019-05-10 18:01 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$51,157
+2,176 vol $23.51 each |
4,267 | |
| Filed 2019-05-10 18:00 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,176 vol |
31,111 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$66,933
+2,841 vol $23.56 each |
3,065 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-22,947.44
-974 vol $23.56 each |
2,091 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-66,933.96
-2,841 vol $23.56 each |
33,287 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+15,221 vol |
36,128 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+44,290 vol |
114,816 | |
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,526 | ||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
20,907 | ||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
224 | ||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
McKenna, Mark
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
6,541 |